QuantaMatrix: QuantaMatrix wins 11 million bid to supply microbiology diagnostics to French public hospitals

QuantaMatrix, an in vitro diagnostics company, said on Thursday that it won a tender valued at €11 million ($15.4 billion) to exclusively supply its direct & Rapid Antimicrobial Susceptibility Test (dRAST) for four years to public hospitals in France. QuantaMatrix was selected by Union des Hôpitaux